CAMBRIDGE, Mass., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today ...
The regional agency asked for the research to be undertaken aas the prospect of local projects have become a hot button issue.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback